TY  - JOUR
PY  - 2020//
TI  - Factors associated with mortality after surgical management of femoral neck fractures
JO  - Journal of Orthopaedic Trauma
A1  - Bzovsky, Sofia
A1  - Comeau-Gauthier, Marianne
A1  - Schemitsch, Emil H.
A1  - Swiontkowski, Marc
A1  - Heels-Ansdell, Diane
A1  - Frihagen, Frede
A1  - Bhandari, Mohit
A1  - Sprague, Sheila
SP  - S15
EP  - S21
VL  - 34
IS  - Suppl 3
N2  - BACKGROUND: Hip fractures are recognized as one of the most devastating injuries impacting older adults because of the complications that follow. Mortality rates postsurgery can range from 14% to 58% within one year of fracture. We aimed to identify factors associated with increased risk of mortality within 24 months of a femoral neck fracture in patients aged ≥50 years enrolled in the FAITH and HEALTH trials.     METHODS: Two multivariable Cox proportional hazards regressions were used to investigate potential prognostic factors that may be associated with mortality within 90 days and 24 months of hip fracture.     RESULTS: Ninety-one (4.1%) and 304 (13.5%) of 2247 participants died within 90 days and 24 months of suffering a femoral neck fracture, respectively. Older age (P < 0.001), lower body mass index (P = 0.002), American Society of Anesthesiologists (ASA) class III/IV/V (P = 0.004), use of an ambulatory aid before femoral neck fracture (P < 0.001), and kidney disease (P < 0.001) were associated with a higher risk of mortality within 24 months of femoral neck fracture. Older age (P = 0.03), lower body mass index (P = 0.02), use of an ambulatory aid before femoral neck fracture (P < 0.001), and having a comorbidity (P = 0.04) were associated with a higher risk of mortality within 90 days of femoral neck fracture.     CONCLUSIONS: Our analysis found that factors that are indicative of a poorer health status were associated with a higher risk of mortality within 24 months of femoral neck fracture. We did not find a difference in treatment methods (internal fixation vs. joint arthroplasty) on the risk of mortality.     LEVEL OF EVIDENCE: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.<p />  <p>Language: en</p>
LA  - en
SN  - 0890-5339
UR  - http://dx.doi.org/10.1097/BOT.0000000000001937
ID  - ref1
ER  -